The SCC 2025 Conference
This year’s Safer Cancer Care Conference took place in Brussels on March 7th 2025. Since our 2023 event there has been much change in Europe regards increasing awareness and protections for all healthcare workers who are exposed to hazardous drugs therefore, it was important to gather together once again to hear expert presentations and discuss the impact these changes will have now and in the future for healthcare establishments.
The Safer Cancer Care Clinical Board welcomed pharmacists, nurses, veterinarians and home healthcare members from Europe and the United Kingdom and once again, Safer Cancer Care was sponsored equally by the industry who are driven to protect those who work clinically and on whom we all rely. The agenda and presentations were independent of any industry sponsorship.
Please visit our 2025 conference page to view our expert speakers and to view the conference gallery and also the film for free (film will be available in May 2025).
The European Commission said that more than 100,000 cancer deaths each year were attributed to occupational exposure to carcinogenic substances, making cancer the first cause of work-related deaths in the EU.
Every year more than 12.7 million health workers, mostly women, in Europe are potentially exposed to carcinogenic, mutagenic and reprotoxic hazardous drugs, including cytotoxic or antineoplastic drugs.
Studies show that nurses exposed to cytotoxic drugs are twice as likely to miscarry and that hospital workers who handle cytotoxic drugs are three times more likely to develop malignancy. Increased genetic damage has been demonstrated in nurses, particularly in day hospital nurses, the group handling the highest amount of drugs during the administration process.
Ian Lindsley, EBN Secretary, SCC 2023.
